Cost-Utility of Active Surveillance for the Treatment of Localized Prostate Cancer in the Context of the German Health Care System

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.540
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation and Active Treatment Versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer

Journal of Urology
Urology
2019English

When Is Active Surveillance the Appropriate Treatment for Prostate Cancer?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Risk Stratification: A Tool to Predict the Course of Active Surveillance for Localized Prostate Cancer?

BJU International
Urology
2016English

Patient Perspective on Watchful Waiting/Active Surveillance for Localized Prostate Cancer

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2012English

Active Surveillance for Prostate Cancer

International Journal of Urology
Urology
2015English

Active Surveillance for Prostate Cancer Compared With Immediate Treatment

Cancer
Cancer ResearchOncology
2011English

Watchful Waiting vs. Active Surveillance: Which Treatment Option Is Right for Patients With Localized Prostate Cancer?

Urology & Nephrology Open Access Journal
2018English

Active Surveillance in Prostate Cancer

Üroonkoloji Bülteni
2017English

The German Health-Care System

Mayo Clinic Proceedings
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy